Lindbrook Capital, LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$26,500
-0.0%
283
-4.7%
0.00%0.0%
Q2 2023$26,507
-45.5%
297
-34.6%
0.00%
-50.0%
Q1 2023$48,678
-25.4%
454
-15.0%
0.01%
-25.0%
Q4 2022$65,217
+27.9%
534
+8.8%
0.01%
-11.1%
Q3 2022$51,000
+6.2%
491
-4.3%
0.01%
+12.5%
Q2 2022$48,000
+2.1%
513
+29.2%
0.01%
+14.3%
Q1 2022$47,000
-13.0%
397
-0.3%
0.01%
-12.5%
Q4 2021$54,000
-35.7%
398
-24.2%
0.01%
-63.6%
Q3 2021$84,000
+18.3%
525
-2.2%
0.02%
+37.5%
Q2 2021$71,000
+24.6%
537
+22.0%
0.02%
+23.1%
Q1 2021$57,000
-17.4%
440
+6.8%
0.01%
-23.5%
Q4 2020$69,000
+9.5%
412
+0.7%
0.02%0.0%
Q3 2020$63,000
+37.0%
409
+31.9%
0.02%
+21.4%
Q2 2020$46,0000.0%310
-24.4%
0.01%
-17.6%
Q1 2020$46,000
-65.2%
410
-56.9%
0.02%
-63.0%
Q4 2019$132,000
+61.0%
952
+11.7%
0.05%
+48.4%
Q3 2019$82,000
+54.7%
852
+83.2%
0.03%
+55.0%
Q2 2019$53,000
-32.1%
465
-30.1%
0.02%
-35.5%
Q1 2019$78,000
+44.4%
665
-23.1%
0.03%
+14.8%
Q4 2018$54,0008650.03%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders